Stem Cells Translational Medicine

Scope & Guideline

Unlocking the Potential of Stem Cell Technology

Introduction

Explore the comprehensive scope of Stem Cells Translational Medicine through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Stem Cells Translational Medicine in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2157-6564
PublisherOXFORD UNIV PRESS
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2012 to 2024
AbbreviationSTEM CELL TRANSL MED / Stem Cells Transl. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The journal 'Stem Cells Translational Medicine' is dedicated to advancing the field of stem cell research and its application in regenerative medicine. It focuses on the translational aspects of stem cell science, bridging the gap between laboratory research and clinical practice.
  1. Stem Cell Therapy Applications:
    The journal emphasizes the clinical applications of various stem cell types, including mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and their derivatives for treating a wide array of diseases, particularly in regenerative medicine.
  2. Mechanisms of Stem Cell Function:
    Research on the biological mechanisms underlying stem cell differentiation, proliferation, and functionality, including studies on signaling pathways, cellular interactions, and the effects of the microenvironment.
  3. Development of Novel Therapeutics:
    Focus on the development and evaluation of new therapeutic strategies utilizing stem cells, including engineered cell products and cell-derived extracellular vesicles, to enhance treatment efficacy.
  4. Regulatory and Ethical Considerations:
    Exploration of regulatory frameworks, ethical implications, and standardization in the use of stem cells and their derivatives in clinical settings.
  5. Translational Research Methodologies:
    Utilization of innovative research methodologies and technologies, such as 3D bioprinting, bioengineering, and high-throughput screening, to facilitate the translation of stem cell research into clinical practice.
The journal has seen a rise in interest in several emerging themes, reflecting the evolving landscape of stem cell research and its application in translational medicine. These trends highlight novel approaches and areas of research that are gaining traction.
  1. Extracellular Vesicles and Secretomes:
    There is an increasing focus on the therapeutic potential of extracellular vesicles derived from stem cells, particularly in their ability to mediate paracrine effects and provide a cell-free alternative for regenerative therapies.
  2. Personalized Medicine Approaches:
    Research is trending towards personalized medicine, where stem cell therapies are tailored to individual patient profiles, leveraging iPSCs derived from patients for disease modeling and customized treatment strategies.
  3. 3D Bioprinting and Tissue Engineering:
    Innovative methodologies such as 3D bioprinting are emerging as key areas, enabling the creation of complex tissue constructs that can better mimic natural tissue architecture for regenerative applications.
  4. Immunomodulation and Inflammation Control:
    Increasing attention is being paid to the immunomodulatory properties of stem cells, particularly MSCs, in managing inflammation and enhancing tissue repair, highlighting their dual role as both therapeutic agents and modulators of the immune response.
  5. Regenerative Strategies for Specific Diseases:
    Focused research on specific diseases, such as neurodegenerative disorders and chronic inflammatory conditions, is trending, showcasing targeted approaches for using stem cells in precision medicine.

Declining or Waning

While 'Stem Cells Translational Medicine' continues to thrive in various research areas, certain themes are witnessing a decline in publication frequency and focus, reflecting shifts in scientific interest or advancements in related fields.
  1. Basic Stem Cell Biology Studies:
    There has been a noticeable decline in publications strictly focused on fundamental stem cell biology without direct translational implications, as the field shifts towards more applied research.
  2. Non-Cell-Based Therapeutics:
    Research focusing on non-cell-based therapeutic interventions, such as small molecules or traditional drug therapies, is becoming less prominent in the context of the journal's focus on cell-based therapies.
  3. Animal Models in Preclinical Studies:
    There is a diminishing trend in studies that predominantly rely on animal models for testing stem cell therapies, as researchers increasingly seek alternative models that better mimic human physiology.
  4. Single Therapeutic Approaches:
    The trend is moving away from studies advocating single therapeutic approaches, with more research emphasizing combinatorial therapies that integrate multiple modalities for enhanced efficacy.

Similar Journals

Tissue Engineering Part A

Empowering Scientists to Redefine Regenerative Medicine
Publisher: MARY ANN LIEBERT, INCISSN: 1937-3341Frequency: 24 issues/year

Tissue Engineering Part A is a prestigious peer-reviewed journal published by MARY ANN LIEBERT, INC that focuses on innovative research and advancements within the field of tissue engineering and regenerative medicine. Since its inception in 2008, this journal has played a critical role in disseminating cutting-edge findings that bridge the gap between laboratory research and clinical application, underscoring its significance in the scientific community. With a diverse scope encompassing biochemistry, bioengineering, biomaterials, and biomedical engineering, the journal ranks notably in the Scopus database, holding a Q2 quartile status across multiple categories, thus reflecting its high impact on ongoing research and professional practice. For researchers, professionals, and students, Tissue Engineering Part A serves as an invaluable resource, offering insights into the latest methodologies and breakthroughs that drive the future of healthcare and therapeutic strategies. While primarily a subscription-based journal, it ensures that vital research is accessible to a broad audience of scientists and engineers committed to advancing the life sciences.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Innovating Insights into Animal Biology
Publisher: SPRINGERISSN: 1071-2690Frequency: 10 issues/year

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, published by SPRINGER, is a pivotal journal in the fields of cell biology and developmental biology, focusing on in vitro studies that enhance our understanding of animal cellular mechanisms and development. With an ISSN of 1071-2690 and an E-ISSN of 1543-706X, this esteemed journal offers a platform for researchers to present their findings and contribute to the body of knowledge necessary for advancements in biological sciences. As a recognized publication, it holds a 2023 category quartile of Q4 in Cell Biology and Developmental Biology, and Q3 in miscellaneous Medicine, reflecting its competitive position yet inviting critical submissions that can span multidisciplinary approaches. Though currently not open access, it serves as an essential resource for professionals, researchers, and students dedicated to unraveling the complexities of cellular processes in an ever-evolving field. The journal has been continuously published since 1986, signifying its long-standing commitment to fostering scientific discourse and innovation.

CELL RESEARCH

Exploring Innovations in Molecular Biology
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

DIFFERENTIATION

Illuminating the Pathways of Molecular Processes
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

CYTOTHERAPY

Pioneering Innovations in Regenerative Medicine.
Publisher: ELSEVIER SCI LTDISSN: 1465-3249Frequency: 12 issues/year

CYTOTHERAPY is a distinguished journal published by Elsevier Science Ltd, focusing on the critical fields of cell therapy, transplantation, and regenerative medicine. Since its inception in 1999, the journal has established itself as a vital resource for researchers and practitioners, contributing significantly to advancements in Cancer Research, Cell Biology, Genetics, Immunology, and Oncology. With an impressive range of Q2 rankings across multiple categories and a remarkable Q1 standing in Transplantation for 2023, CYTOTHERAPY delivers high-impact research that addresses the evolving challenges in these fields. While the journal does not offer open access, it remains a reputable avenue for disseminating pivotal studies and reviews that push the boundaries of cell-based therapies. Researchers, clinicians, and students alike will find CYTOTHERAPY an indispensable platform to stay abreast of the latest discoveries and innovations that are shaping the future of medical science.

International Journal of Stem Cells

Unlocking the Potential of Cell Biology
Publisher: KOREAN SOC STEM CELL RESEARCHISSN: 2005-3606Frequency: 2 issues/year

The International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.

Stem Cells International

Empowering Knowledge in Regenerative Biology
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Stem Cell Research

Leading the conversation on ethical stem cell applications.
Publisher: ELSEVIERISSN: 1873-5061Frequency: 6 issues/year

Stem Cell Research is a premier Open Access journal published by ELSEVIER, dedicated to advancing the understanding of stem cell biology. Since its inception in 2007, the journal has provided a platform for the latest research in the fields of Cell Biology, Developmental Biology, and Medicine, with its publication being accessible globally since 2014. Located in the Netherlands, the journal’s comprehensive scope aims to bridge fundamental discoveries with clinical applications, fostering collaboration among researchers and professionals. With a 2023 impact factor reflected in its Q4 ranking in Cell and Developmental Biology and a commendable position in the 64th percentile for General Medicine, Stem Cell Research remains a vital resource for those interested in the dynamic landscape of regenerative medicine. Targeting an audience that includes researchers, practitioners, and students, the journal emphasizes not only the significance of stem cells in medical science but also the ethical considerations and the public discourse surrounding stem cell research. Join the community committed to pioneering the future of stem cell science through rigorous peer-reviewed research.

Cell Stem Cell

Pioneering Insights in Cellular Biology and Regenerative Medicine
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

TRENDS IN CELL BIOLOGY

Transforming Understanding of Cellular Complexity
Publisher: CELL PRESSISSN: 0962-8924Frequency: 12 issues/year

TRENDS IN CELL BIOLOGY, published by CELL PRESS, is a premier journal in the field of cell biology, recognized for its high-impact contributions since its inception in 1991. As a distinguished member of the Q1 quartile within its category, the journal holds an impressive Scopus ranking of #8 out of 285, placing it in the 97th percentile of the field, which underscores its reputation for excellence. The journal serves as an essential resource for researchers, professionals, and students who are engaged with groundbreaking advancements in biochemistry, genetics, and molecular biology. Although it is not open access, it provides critical insights into the latest trends, reviews, and advancements in cell biology, making it a crucial tool for anyone committed to understanding the complexities of cellular systems. With a focus on innovative and transformative research, TRENDS IN CELL BIOLOGY continues to shape the discourse in cell biology and enhance the scientific community's knowledge.